Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2005, p. 1633-1635, Vol. 49, No. 4
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.4.1633-1635.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
College of Pharmacy, University of Minnesota, Minneapolis,1 Saint John's University, Collegeville, Minnesota2
Received 20 May 2004/ Returned for modification 15 September 2004/ Accepted 23 November 2004
The purpose of this study was to compare the mutant prevention concentration (MPC) of ABT-492 to those of levofloxacin, moxifloxacin, and gatifloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. The fluoroquinolones had comparable mutation selection windows, which is the ratio of MPC/MIC, for all isolates.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»